Literature DB >> 6683482

The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein.

T Katada, M Tamura, M Ui.   

Abstract

Islet-activating protein (IAP), pertussis toxin, is an oligomeric protein composed of as A protomer and a B oligomer. IAP and its A protomer were equipotent, on a molar basis, in enhancing GTP-dependent adenylate cyclase activity and in causing ADP-ribosylation of the 41,000 Mr protein when directly added to the cell-free membrane preparation from rat C6 glioma cells. Similar actions of IAP observed upon its addition to intact C6 cells were not mimicked by its A protomer, indicating that the A protomer had to be associated with the B oligomer to become accessible to its site of action on the inner surface of the membrane of intact cells. The A protomer, but not IAP, exhibited NAD-glycohydrolase activity in the reaction mixture lacking cellular components but containing dithiothreitol. Their actions on membranes were not accelerated by dithiothreitol, but markedly suppressed by oxidized glutathione. Thus, C6 cell membranes may possess certain "processing" enzyme(s) responsible for releasing the A protomer from the IAP molecule and for reductive cleavage of an intrachain disulfide bond in the released protomer, thereby producing an active peptide which functions to cause ADP-ribosylation of one of the subunits of guanine nucleotide regulatory protein in the receptor-adenylate cyclase system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6683482     DOI: 10.1016/0003-9861(83)90212-6

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  68 in total

1.  Importance of holotoxin assembly in Ptl-mediated secretion of pertussis toxin from Bordetella pertussis.

Authors:  K M Farizo; T Huang; D L Burns
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis.

Authors:  Trevor H Stenson; Alison A Weiss
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

3.  Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion.

Authors:  Karen M Farizo; Stefanie Fiddner; Anissa M Cheung; Drusilla L Burns
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

4.  Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Charlotte Andreasen; Edward Dudley; R Michael Mays; Zoe E V Worthington
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

5.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

6.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

7.  The RNA chaperone Hfq is required for virulence of Bordetella pertussis.

Authors:  Ilona Bibova; Karolina Skopova; Jiri Masin; Ondrej Cerny; David Hot; Peter Sebo; Branislav Vecerek
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

8.  Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose.

Authors:  G D Armstrong; M S Peppler
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  Identification and characterization of PtlC, an essential component of the pertussis toxin secretion system.

Authors:  D M Cook; K M Farizo; D L Burns
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

10.  Development of inhibitors of heterotrimeric Gαi subunits.

Authors:  Kathryn M Appleton; Kevin J Bigham; Christopher C Lindsey; Starr Hazard; Jonel Lirjoni; Stuart Parnham; Mirko Hennig; Yuri K Peterson
Journal:  Bioorg Med Chem       Date:  2014-04-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.